Identifying The Patient Journey And Treatment Lines Patterns In Metastatic Pancreatic Cancer​
Researched by Belong.Life and published by ASCO, 2018 Authors: Daniel Vorobiof, Irad Deutsch, Eliran Malki, Maytal Bivas-Benita Introduction: Checkpoint inhibitors such as programmed cell death receptor 1 (PD-1) antibodies have significantly improved the prognosis in several malignancies. While treatment with the PD-1 targeting antibodies, pembrolizumab and nivolumab, has substantial clinical benefit, it is associated with […]
Mapping PD-1 Inhibitors’ Side Effects Using Patient Reported Outcomes
Researched by Belong.Life and published by ASCOData from the Belong PPN successfully captured the spectrum of PD-1 inhibitors’ reported AEs. Analyzing PRO of post approval treatments could provide deeper understanding of treatment patterns, expose limiting AE that bear implications on cost of treatment, indicate patients’ quality of life (QOL), improve management recommendations and provide a […]
Unveiling The Real-World Outcomes Of Breast Cancer Patients With Taxanes-Induced Neuropathy Using A Digital Patient-Powered Network
Researched by Belong.Life and published by ASCO, 2019 Authors: Raanan Berger, Lior Hasid, Irad Deutsch, Eliran Malki, Maytal Bivas-Benita Background: Taxanes-induced neuropathy is common in BC patients receiving taxanes, forcing dose reductions and treatment delays and posing serious challenges for the long-term patient QoL. Discovering neuropathy predictors in patients could guide better treatment decisions, improved […]
Creating The Real-World Medical Record: Using Digital Patient-Generated Data To Create An Updated Picture Of Patients Outcomes
Researched by Belong.Life and published by ASCO, 2019 Authors: Maytal Bivas-Benita , Irad Deutsch, Eliran Malki, Lior Hasid Background: Value-based healthcare requires integration of real-world data (RWD) generated by patients in parallel to clinical documentation. This gives a holistic perspective of the patients’ health and care and could lead to reduced costs and better patient […]
Patients Reported Outcomes In Breast Cancer: Physical, Emotional Side Effects, Financial Toxicity, And Complementary Usage Relations
Researched by Belong.Life and published by ASCO, 2019 Authors: Daniel A. Vorobiof, Eliran Malki, Irad Deutsch, Lior Hasid Background: RWD denotes data accumulated via electronic health records as well as cutting edge technology paired with consumer mobile devices. Artificial intelligence (AI) incorporates the use of algorithms and machine learning (ML) software to analyze complex medical […]
Advanced Breast Cancer Patients, Focusing On Patient’s Reported Outcomes In Reducing The Burden Of Financial Toxicity
Researched by Belong.Life, Published by the The Breast. 2019 A targeted survey of Belong.life Advanced Breast Cancer (ABC) patients (pts), focusing on patient’s reported outcomes (PROs), real world evidence (RWE) and insights in reducing the burden of financial toxicity (FT) Background: 151 ABC pts, active Belong.life users, the world largest, anonymous and free social media […]
Implementation of a Person Centered e-Health Platform in Gynecological Cancer Care In JGH​
Researched By Belong.Life with JGH and Presented by McGill University, 2019 This study was conducted by McGill University and the Jewish General Hospital in Toronto, Canada, using the Belong.life platform. Authors: Saima Ahmed, Walter H. Gotlieb, Guy Erez , Carmen G. Loiselle Introduction: Enhanced population health is increasingly supported by e-health – defined as technological […]
Financial Toxicity In Cancer Patients Receiving Immunotherapy Drugs
Researched by Belong.Life and published by ESMO, 2020 Authors: D Vorobiof, L Hasid, A Litvin, I Deutsch, E Malki. FT has been described as the harmful personal financial burden faced by all patients receiving cancer treatments. Physicians should not be waiting for behavioural changes such as poor compliance, or low or nonadherence, caused by financial […]
Financial Toxicity in American Patients Receiving Cancer Immunotherapy Drugs
Researched by Belong.Life and published by ASCO, 2020Authors: Daniel A. Vorobiof, Lior Hasid, Alon Litvin, Irad Deutsch, Eliran Malki Background: Real-word data obtained through cutting edge technology paired with consumer mobile devices on 310 worldwide pts, members of Belong.life, an international mobile application, who received immunotherapy for diverse solid tumors, was obtained following a short, […]
Physician’s Advice On BRCA Genetic Testing For Ovary And Breast Cancer Patients
Researched by Belong.Life and published by ASCO 2020 Author: Daniel A. Vorobiof Background:The 2019 US Preventive Services Task Force (USPSTF) recommends that women with a personal and familiar history of BC and OC undergo a BRCA genetic testing so that risk assessment, prevention options and treatment changes are considered. Methods:BC and OC members of Belong.life […]
